docetaxel plus cisplatin

DRUG3 trials

Sponsors

Mei Shi, Huai'an First People's Hospital, Samsung Medical Center

Conditions

Cervical CancerEsophageal Squamous Cell CarcinomaSalivary Gland CancerToxicity Due to Radiotherapy

Phase 2

Evaluation of Postoperative Radiotherapy and Concurrent Chemotherapy Effectiveness in Cervical Cancer

Mei ShiCervical Cancer, Toxicity Due to Radiotherapy

Start: 2013-11-30End: 2018-11-30Target: 600Updated: 2013-12-03

Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma

CompletedNCT03600831

Huai'an First People's HospitalEsophageal Squamous Cell Carcinoma

Start: 2018-08-20End: 2023-12-31Updated: 2024-01-09

Weekly Docetaxel Plus Cisplatin as First-line Chemotherapy in Metastatic Salivary Gland Cancer Patients : a Multicenter Phase II Study

Samsung Medical CenterSalivary Gland Cancer

Start: 2014-05-02End: 2023-05-31Updated: 2021-08-17

Related Papers

Weekly Cisplatin vs. Triweekly Docetaxel Plus Cisplatin With Concurrent Chemoradiation in Post-Operative Treatment for Cervical Cancer With High-Risk Pathological Factors: A Randomized Controlled Phase III Trial From a Single Institution.

2021-11-01